BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4126721)

  • 1. Survival and relapse rates in Hodgkin's disease: Stanford experience, 1961-71.
    Kaplan HS
    Natl Cancer Inst Monogr; 1973 May; 36():487-96. PubMed ID: 4126721
    [No Abstract]   [Full Text] [Related]  

  • 2. Survival after recurrence: prognostic factors and spread patterns in clinical stages I and II of Hodgkin's disease.
    Tubiana M; van der Werf-Messing B; Laugier A; Hayat M; Henry-Amar M; Attie E; Leroy T
    Natl Cancer Inst Monogr; 1973 May; 36():513-30. PubMed ID: 4744607
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of primary relapses after radiotherapy in Hodgkin's disease.
    Spittle MF; Harmer CL; Cassady JR; Kaplan HS
    Natl Cancer Inst Monogr; 1973 May; 36():497-508. PubMed ID: 4744605
    [No Abstract]   [Full Text] [Related]  

  • 4. International Symposium on Hodgkin's Disease. Session 5. Treatment. Current status of clinical trials: Stanford experience, 1962-72.
    Kaplan HS; Rosenberg SA
    Natl Cancer Inst Monogr; 1973 May; 36():363-71. PubMed ID: 4582994
    [No Abstract]   [Full Text] [Related]  

  • 5. Current studies in Hodgkin's disease: what laparotomy has wrought.
    Hellman S
    N Engl J Med; 1974 Apr; 290(16):894-8. PubMed ID: 4593613
    [No Abstract]   [Full Text] [Related]  

  • 6. Hodgkin's disease: survival and relapse-free data.
    Smithers DW
    Natl Cancer Inst Monogr; 1973 May; 36():509-12. PubMed ID: 4744606
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal.
    DeVita VT
    Natl Cancer Inst Monogr; 1973 May; 36():373-9. PubMed ID: 4744596
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment and prognosis of intrathoracic Hodgkin's disease (author's transl)].
    Jungblut R; Menne HJ
    Dtsch Med Wochenschr; 1975 May; 100(22):1219-24. PubMed ID: 1132336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hodgkin's and non-Hodgkin's lymphomas.
    McElwain TJ
    Br J Hosp Med; 1984 Jan; 31(1):10-4, 18-9. PubMed ID: 6697038
    [No Abstract]   [Full Text] [Related]  

  • 10. Results of treating Hodgkin's disease without a policy of laparotomy staging.
    Bergsagel DE; Alison RE; Bean HA; Brown TC; Bush RS; Clark RM; Chua T; Dalley D; DeBoer G; Gospodarowicz M; Hasselback R; Perrault D; Rideout DF
    Cancer Treat Rep; 1982 Apr; 66(4):717-31. PubMed ID: 7074642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de Moëlle.
    Brice P; Bouabdallah R; Moreau P; Divine M; André M; Aoudjane M; Fleury J; Anglaret B; Baruchel A; Sensebe L; Colombat P
    Bone Marrow Transplant; 1997 Jul; 20(1):21-6. PubMed ID: 9232251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients.
    Brice P; Bastion Y; Divine M; Nedellec G; Ferrant A; Gabarre J; Reman O; Lepage E; Fermé C
    Cancer; 1996 Sep; 78(6):1293-9. PubMed ID: 8826953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hodgkin's disease. Results from a program in radiation therapy.
    Micaily B; Brady LW
    Am J Clin Oncol; 1984 Apr; 7(2):159-71. PubMed ID: 6422736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).
    Lazarus HM; Loberiza FR; Zhang MJ; Armitage JO; Ballen KK; Bashey A; Bolwell BJ; Burns LJ; Freytes CO; Gale RP; Gibson J; Herzig RH; LeMaistre CF; Marks D; Mason J; Miller AM; Milone GA; Pavlovsky S; Reece DE; Rizzo JD; van Besien K; Vose JM; Horowitz MM
    Bone Marrow Transplant; 2001 Feb; 27(4):387-96. PubMed ID: 11313668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
    Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
    Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress report. Hodgkin's clinical trial, 1972.
    Hutchison GB
    Natl Cancer Inst Monogr; 1973 May; 36():387-93. PubMed ID: 4582997
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of Hodgkin's disease.
    Med Lett Drugs Ther; 1974 Aug; 16(17):69-71. PubMed ID: 4135467
    [No Abstract]   [Full Text] [Related]  

  • 18. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I; Ganser D; Freitag EM; Bohndorf W
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Causes for failures in the treatment of localized forms of lymphogranulomatosis].
    Pakulina LE; Chekharina EA
    Vopr Onkol; 1973 May; 19(5):36-41. PubMed ID: 4714734
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influence of age on treatment results in children and adolescents with Hodgkin's disease].
    Balwierz W; Moryl-Bujakowska A; Depowska T; Klekawka T; Stanuch H; Matysiak M; Sopyło B; Kołakowska-Mrozowska B; Krenke K; Chybicka A; Raś M; Sońta-Jakimczyk D; Moszant A; Wachowiak J; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Balcerska A; Drozyńska E; Wysocki M; Kołtan A; Krawczuk-Rybak M; Stolarska M
    Przegl Lek; 2004; 61 Suppl 2():40-4. PubMed ID: 15686044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.